Review Article

Role of Gut-Related Peptides and Other Hormones in the Amelioration of Type 2 Diabetes after Roux-en-Y Gastric Bypass Surgery

Table 3

GIP and RYGB surgery.

Author/yearType of studySubjectsPreop BMI% weight lossF/U timeChange in hormone

Laferrère et al. 2007 [50]Prospective controlled8 F T2D RYGB
7 nondiabetic obese
4 3 . 6 ± 6 . 8
3 7 . 1 ± 1 1 . 6
NA1 moFasting- and glucose-stimulated GIP similar in S and C
1 month after RYGB, increase in GIP in response to oral glucose.
Laferrère et al. 2008 [49]Prospective controlled 9 F T2D RYGB
10 F T2D diet-induced weight loss
4 3 . 3 ± 6 . 2
4 3 . 3 ± 3 . 6
NA1 mo
10 Kg weight loss
No change in fasting GIP in both groups.
Increase in peak GIP after OGTT in RYGB group only.
Rubino et al., 2004 [60]Prospective uncontrolled10 (9 F, 6 T2D) obese RYGB46.2NA3 wkBaseline GIP higher in diabetics compared to nondiabetics.
Decrease in fasting GIP in diabetics only.
Clements et al. 2004 [61]Prospective uncontrolled20 obese (15 F) with T2D 5 2 . 7 ± 8 . 8 NA2, 6 and 12 wk postopDecrease in fasting GIP at 6 and 12 wk.
Whitson et al. 2007 [72]Prospective uncontrolled10 (9 F, 5 T2D)
RYGB
5 0 ± 6 NA6 moNo change in GIP postop (nonfasting).
Kashyap et al. 2010 [73]Prospective uncontrolled16 (7 females)
T2D
9 RYGB
7 GR
4 7 ± 9 10%4 wkNo change in fasting or PP GIP in both groups.
Korner et al. 2007 [58]Cross-sectional controlled13 F RYGB
10 F BND
13 F overweight
3 1 . 3 ± 1 . 3
3 6 . 1 ± 1 . 7
3 6 . 1 ± 2 . 2
3 5 . 6 ± 2 . 4
2 4 . 6 ± 2 . 3
2 4 . 6 ± 2  mo postopBlunted PP GIP peak after RYGB

Abbreviations: BND: adjustable gastric banding, GR: gastric restrictive, NA: data not available, OGTT: oral glucose tolerance test, Postop: postoperatively, PP: postprandial, RYGB: Roux-en-y gastric bypass, T2D: type 2 diabetes.